As laboratories push for higher throughput, greater reproducibility, and more automation‑ready workflows, the industry is increasingly turning to collaboration to solve persistent bottlenecks. Omega Bio‑tek is leaning into that shift. At the 2026 SLAS International Conference & Exhibition, the company is debuting several partnerships designed to streamline nucleic acid purification across a wide range of sample types and applications. For Omega Bio‑tek, the strategy reflects a broader ambition: to support high‑quality nucleic acid purification products for labs of every scale. The company, based in Norcross, GA, manufactures more than 900 DNA and RNA isolation products used in clinical research, biotechnology, genomics, and agriculture. Its nucleic acid extraction techniques—spanning magnetic beads, silica membranes, and salting‑out—are deployed from small academic labs to large CROs. This year’s SLAS announcements underscore that automation‑first mindset. One of the company’s launches is a new automated workflow for blood and saliva DNA extraction, built around the PS6399 Mag‑Bind® Blood & Saliva DNA LSP Kit and integrated on the Hamilton Microlab STAR X. The system is designed to improve inhibitor removal and yield consistency, two persistent challenges for liquid samples with variable composition. The workflow was featured in a Spotlight Talk by Omega Bio-tek’s field applications manager, Jeff Roeder. Omega Bio‑tek will also highlight a specialized magnet used in the workflow. Omega Bio‑tek is also unveiling a fully automated endotoxin‑free plasmid purification workflow developed with Dynamic Devices. The system integrates the M1272 Mag‑Bind® Endo‑free Plasmid Midi Kit with the Dynamic Devices LYNX Robotic Liquid Handler to support high‑quality…
